The possible role of cTnT in COVID-19 prognosis is also exemplified by Guo et al., who reported the elevation of cTnT levels in 52 out of 187 (27.8%) hospitalised COVID-19 patients, all of whom developed myocardial injury [20]. This evidence concerns the gene TNNT2 and COVID-19.